日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

出版商更正:突变型 KRAS 疫苗联合双重免疫检查点阻断治疗切除胰腺癌:一项 I 期试验

Huff, Amanda L; Haldar, S Daniel; Girgis, Alexander A; Wang, Hejia Henry; Danilova, Ludmila; Heumann, Thatcher; Berg, Maureen; Wang, Yuxuan; Andaloori, Lalitya; Hernandez, Alexei; Longway, Gabriella; Barrett, Benjamin; Zhu, Zirui; Davis-Marcisak, Emily; Thoburn, Christopher; Leatherman, James; Mitchell, Sarah; Lee, Jae W; Shu, Daniel H; Konig, Maximillian F; Mog, Brian J; Montagne, Janelle; Coyne, Erin M; Bever, Katherine; Baretti, Marina; Yarchoan, Mark; Anders, Robert A; Kagohara, Luciane T; Laheru, Daniel; Thomas, Amy M; Durham, Jennifer; Nauroth, Julie M; Lu, Jiayun; Wang, Hao; Fertig, Elana J; Ho, Won Jin; Azad, Nilofer S; Jaffee, Elizabeth M; Zaidi, Neeha

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

突变型 KRAS 疫苗联合双重检查点阻断治疗切除的胰腺癌:一项 I 期试验。

Huff Amanda L, Haldar S Daniel, Gergis Alexander A, Wang Hejia Henry, Danilova Ludmila, Heumann Thatcher, Berg Maureen, Wang Yuxuan, Andaloori Lalitya, Hernandez Alexei, Longway Gabriella, Barrett Benjamin, Zhu Zirui, Davis-Marcisak Emily, Thoburn Christopher, Leatherman James, Mitchell Sarah, Lee Jae W, Shu Daniel H, Konig Maximillian F, Mog Brian J, Montagne Janelle, Coyne Erin M, Bever Katherine, Baretti Marina, Yarchoan Mark, Anders Robert A, Kagohara Luciane T, Laheru Daniel, Thomas Amy M, Durham Jennifer, Nauroth Julie M, Lu Jiayun, Wang Hao, Fertig Elana J, Ho Won Jin, Azad Nilofer S, Jaffee Elizabeth M, Zaidi Neeha

Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma

首次注射免疫检查点抑制剂的时间会影响肝细胞癌的临床结果和免疫反应。

Li, Howard L; Charmsaz, Soren; Reisman, Benjamin J; Hayek, Franshisca; Brancati, Madelena; Leatherman, James M; Pazzi, Carlotta; Lee, Royce P; Zhao, Xiyu; Christenson, Eric; Arif, Waqar; Hernandez, Jeric; Ellis, Caroline; Gross, Nicole E; Thoburn, Chris; Chandler, G Scott; Mohindra, Rajat; Bansal, Sanjay; Tang, Laura; Guha, Aditi; Dang, Chi V; Zaidi, Neeha; Jaffee, Elizabeth M; Laheru, Daniel; Zabransky, Daniel J; Barretti, Marina; Ho, Won Jin; Yarchoan, Mark; Nakazawa, Mari

Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses

胰腺癌联合免疫疗法的细胞计量图谱:基于血液的特征揭示疫苗和检查点抑制剂的反应

Sidiropoulos, Dimitrios N; Zhang, Zhehao; Durham, Jennifer N; Charmsaz, Soren; Gross, Nicole E; Lee, Jae W; Sun, Yanyi; Perikala, Susheel; Tandurella, Joseph A; Lvovs, Dmitrijs; Mitschang, Arik; Lemson, Gerard; Shin, Sarah M; Hernandez, Alexei G; Mitchell, Sarah; Leatherman, James M; Danilova, Ludmila; Wang, Hao; Fertig, Elana J; Jaffee, Elizabeth M; Bever, Katherine M; Le, Dung T; Ho, Won Jin

Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma.

肿瘤来源的 CCL2 驱动 IDH1 突变型胆管癌的肿瘤生长和免疫抑制

Zabransky Daniel J, Kartalia Emma, Lee Jae W, Leatherman James M, Charmsaz Soren, Young Sara E, Chhabra Yash, Franch-Expósito SebastiÃ, Kang Martin, Maru Saumya, Rastkari Noushin, Davis Michael, Dalton William Brian, Oshima Kiyoko, Baretti Marina, Azad Nilofer S, Jaffee Elizabeth M, Yarchoan Mark

Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors

接受免疫检查点抑制剂治疗的实体瘤患者循环免疫反应的年龄相关性差异

Kao, Chester; Charmsaz, Soren; Tsai, Hua-Ling; Aziz, Khaled; Shu, Daniel H; Munjal, Kabeer; Griffin, Ervin; Leatherman, James M; Lipson, Evan J; Ged, Yasser; Hoffman-Censits, Jeannie; Li, Howard L; Hallab, Elsa; Brancati, Madelena; Nakazawa, Mari; Alden, Stephanie; Thoburn, Christopher; Gross, Nicole E; Hernandez, Alexei G; Coyne, Erin M; Kartalia, Emma; Baretti, Marina; Jaffee, Elizabeth M; Bansal, Sanjay; Tang, Laura; Chandler, G Scott; Mohindra, Rajat; Ho, Won Jin; Yarchoan, Mark; Zabransky, Daniel J

Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures

接受免疫治疗的实体瘤患者的免疫相关事件与 Th17 和 Th2 特征相关。

Kao, Chester J; Charmsaz, Soren; Alden, Stephanie L; Brancati, Madelena; Li, Howard L; Balaji, Aanika; Munjal, Kabeer; Howe, Kathryn; Mitchell, Sarah; Leatherman, James; Griffin, Ervin; Nakazawa, Mari; Tsai, Hua-Ling; Danilova, Ludmila; Thoburn, Chris; Gizzi, Jennifer; Gross, Nicole E; Hernandez, Alexei; Coyne, Erin M; Shin, Sarah M; Suresh Babu, Jayalaxmi; Apostol, George W; Durham, Jennifer; Christmas, Brian J; Konig, Maximilian F; Lipson, Evan J; Naidoo, Jarushka; Cappelli, Laura C; Pabani, Aliyah; Ged, Yasser; Baretti, Marina; Brahmer, Julie; Hoffman-Censits, Jean; Seiwert, Tanguy Y; Garonce-Hediger, Rachel; Guha, Aditi; Bansal, Sanjay; Tang, Laura; Jaffee, Elizabeth M; Chandler, G Scott; Mohindra, Rajat; Ho, Won Jin; Yarchoan, Mark

Anti-CTLA4 Therapy Leads to Early Expansion of a Peripheral Th17 Population and Induction of Th1 Cytokines

抗CTLA4疗法导致外周Th17细胞群早期扩增和Th1细胞因子诱导

Nakazawa, Mari; Charmsaz, Soren; Hallab, Elsa; Fang, Mike; Kao, Chester; Brancati, Madelena; Munjal, Kabeer; Li, Howard L; Leatherman, James M; Griffin, Ervin; Thoburn, Christopher J; Lipson, Evan J; Ged, Yasser; Hoffman-Censits, Jean; Baretti, Marina; Tang, Laura; Bansal, Sanjay; Garonce-Hediger, Rachel; Guha, Aditi; Chandler, G Scott; Mohindra, Rajat; Jaffee, Elizabeth M; Ho, Won Jin; Yarchoan, Mark

Neoadjuvant Immunotherapy Promotes the Formation of Mature Tertiary Lymphoid Structures in a Remodeled Pancreatic Tumor Microenvironment

新辅助免疫疗法促进重塑的胰腺肿瘤微环境中成熟三级淋巴结构的形成

Sidiropoulos, Dimitrios N; Shin, Sarah M; Wetzel, Meredith; Girgis, Alexander A; Bergman, Daniel; Danilova, Ludmila; Perikala, Susheel; Shu, Daniel; Montagne, Janelle M; Deshpande, Atul; Leatherman, James; Dequiedt, Lucie; Jacobs, Victoria; Ogurtsova, Aleksandra; Mo, Guanglan; Yuan, Xuan; Lvovs, Dmitrijs; Stein-O'Brien, Genevieve; Yarchoan, Mark; Zhu, Qingfeng; Harper, Elizabeth I; Weeraratna, Ashani T; Kiemen, Ashley L; Jaffee, Elizabeth M; Zheng, Lei; Ho, Won Jin; Anders, Robert A; Fertig, Elana J; Kagohara, Luciane T

A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages

一项针对转移性胰腺腺癌的 CXCR4 拮抗剂和 PD1 抑制剂的 2 期试验表明,这些药物可以募集 T 细胞,但也会募集免疫抑制性巨噬细胞。

Bever, Katherine M; Shin, Sarah M; Durham, Jennifer N; Qi, Hanfei; Hernandez, Alexei; Coyne, Erin M; Gross, Nicole E; Charmsaz, Soren; Suresh Babu, Jayalaxmi; Vargas Carvajal, Diana Carolina; Verma, Rohan; Sun, Yanyi; Zhang, Zhehao; Yuan, Xuan; Cannon, Courtney D; Hughes, Sarah N; Mitchell, Sarah; Figlewski, Madeline; Leatherman, James M; Wang, Hao; Anders, Robert A; Jaffee, Elizabeth M; Le, Dung T; Ho, Won Jin